Shinichi Sameshima

Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)

Kei Muro, Narikazu Boku, Yasuhiro Shimada et al. · The Lancet Oncology · 2010 · 217 citations

Oncology, Firis Study, Medicine +8

Impact of Autonomic Nerve Preservation and Lateral Node Dissection on Male Urogenital Function after Total Mesorectal Excision for Lower Rectal Cancer

Kennoki Kyo, Shinichi Sameshima, Minoru Takahashi et al. · World Journal of Surgery · 2006 · 87 citations

Squamous Cell Carcinoma of Anus and Carcinoma in Association with Anal Fistula in Japan, Multi-institutional Registration

Shinichi Sameshima, T. Sawada, Kou Nagasako · Nihon Daicho Komonbyo Gakkai Zasshi · 2005 · 48 citations · Full text

A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study

Hirofumi Yasui, Kei Muro, Yasuhiro Shimada et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 22 citations · Full text

Firis Study, Medicine, Pharmacology +8

Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study

Takashi Okuyama, Shinichi Sameshima, Emiko Takeshita et al. · World Journal of Surgical Oncology · 2018 · 19 citations · Full text